Standex International (SXI) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
18 Jan, 2026Executive summary
Q1 FY25 net sales declined 7.7% year-over-year to $170.5M, with organic sales down 11.4% and acquisitions partially offsetting the decline.
Achieved record gross margin of 41.1%, up 160bps year-over-year and 240bps sequentially, and operating margin near 16%.
Largest acquisition in company history: Amran Instrument Transformers & Narayan Powertech for $462M, expanding presence in high-margin electrical grid markets and expected to be immediately accretive to revenue, margins, EPS, and free cash flow.
New product sales increased 20% year-over-year to $11M, with over a dozen new products planned for FY25.
Exposure to fast-growth markets doubled to 25% of sales on a pro forma FY24 basis post-acquisition.
Financial highlights
Adjusted operating margin was flat at 15.9%; adjusted operating income fell 8% to $27.0M.
Adjusted EPS decreased 1.7% to $1.71; diluted EPS was $1.53.
Free cash flow was $10.8M, down from $12.1M a year ago; operating cash flow from continuing operations was $17.5M.
Declared 241st consecutive quarterly dividend, $0.32/share, up 6.7% year-over-year.
Cash and cash equivalents at quarter-end were $164.6M; long-term debt stood at $149.0M.
Outlook and guidance
Q2 FY25 revenue and margin expected to improve sequentially, driven by the Amran-Narayan acquisition and recovering demand in electronics and specialty.
Anticipate mid- to high-single-digit organic growth in electronics in Q3 and Q4 FY25; engineering technologies to continue double-digit growth.
Over a dozen new products planned for FY25, contributing incremental growth.
Updated long-term financial outlook to be provided in Q2 FY25 earnings call.
Restructuring costs of approximately $4.0M expected for the remainder of FY2025.
Latest events from Standex International
- Record profit, margin gains, and new launches set up >20% fast market growth for FY25.SXI
Q4 20242 Feb 2026 - Q2 FY26 delivered double-digit sales growth, margin expansion, and record order intake.SXI
Q2 20262 Feb 2026 - Record sales and margins driven by acquisitions, but net income and cash flow declined.SXI
Q2 20259 Jan 2026 - Record margins and 17.2% sales growth driven by acquisitions and fast growth markets.SXI
Q3 202523 Dec 2025 - Proxy covers director elections, pay, governance, risk, and ESG, with all proposals recommended.SXI
Proxy Filing1 Dec 2025 - Annual meeting covers director elections, incentive plan, pay, by-law, auditor, and ESG focus.SXI
Proxy Filing1 Dec 2025 - 2025 meeting covers director elections, say-on-pay, auditor ratification, and ESG priorities.SXI
Proxy Filing1 Dec 2025 - Shareholders will vote on a By-Law Amendment needing 80% approval, with Board support.SXI
Proxy Filing1 Dec 2025 - Record Q4 sales and margin expansion set up $100M+ revenue growth and new launches in FY26.SXI
Q4 202516 Nov 2025